Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Influenza

Free Subscription 10.06.2019 1 J Gen Virol 1 J Infect Dis 1 J Virol 3 PLoS One 8 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

J Gen Virol

1. HUSSAIN S, Turnbull ML, Pinto RM, McCauley JW, et al
   Segment 2 from influenza A(H1N1) 2009 pandemic viruses confers temperature-sensitive haemagglutinin yield on candidate vaccine virus growth in eggs that can be epistatically complemented by PB2 701D.
   J Gen Virol. 2019 Jun 6. doi: 10.1099/jgv.0.001279.
   PubMed     Text format     Abstract available
   
   

   
   J Infect Dis

2. ZHONG W, Levine MZ
   Stockpiled avian influenza A(H7N9) vaccines induce robust, non-neutralizing functional antibodies against antigenically drifted 5th wave A(H7N9) viruses.
   J Infect Dis. 2019 Jun 5. pii: 5511958. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   J Virol

3. KIM JI, Lee S, Lee GY, Park S, et al
   Novel small molecule targeting the hemagglutinin stalk of influenza viruses.
   J Virol. 2019 Jun 5. pii: JVI.00878-19. doi: 10.1128/JVI.00878.
   PubMed     Text format     Abstract available
   
   

   
   PLoS One

4. PILLET S, Couillard J, Trepanier S, Poulin JF, et al
   Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-Two randomized Phase II clinical trials in 18 to 49 and >/=50 years old adults.
   PLoS One. 2019;14:e0216533.
   PubMed     Text format     Abstract available
   
   
5. KARMACHARYA D, Manandhar S, Sharma A, Bhatta T, et al
   Correction: Surveillance of Influenza A Virus and Its Subtypes in Migratory Wild Birds of Nepal.
   PLoS One. 2019;14:e0218344.
   PubMed     Text format     Abstract available
   
   
6. KIM WJ, Hur KY, Park HW, Lee SW, et al
   Pathogenicity of the H1N1 influenza virus enhanced by functional synergy between the NPV100I and NAD248N pair.
   PLoS One. 2019;14:e0217691.
   PubMed     Text format     Abstract available
   
   

   
   Vaccine

7. NICOLODI C, Groiss F, Kiselev O, Wolschek M, et al
   Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1.
   Vaccine. 2019 May 30. pii: S0264-410X(19)30627.
   PubMed     Text format     Abstract available
   
   
8. YAKUBOGULLARI N, Genc R, Coven F, Nalbantsoy A, et al
   Development of adjuvant nanocarrier systems for seasonal influenza A (H3N2) vaccine based on Astragaloside VII and gum tragacanth (APS).
   Vaccine. 2019 May 30. pii: S0264-410X(19)30662.
   PubMed     Text format     Abstract available
   
   
9. WEHBI NK, Wani RJ, Klepser DG, Murry J, et al
   Impact of implementing a technology platform in community pharmacies to increase adult immunizations rates.
   Vaccine. 2019;37:56-60.
   PubMed     Text format     Abstract available
   
   
10. GILBERT BE, Patel N, Lu H, Liu Y, et al
    Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
    Vaccine. 2018 Oct 30. pii: S0264-410X(18)31458.
    PubMed     Text format     Abstract available
    
    
11. ZHANG L, Durr E, Galli JD, Cosmi S, et al
    Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31398.
    PubMed     Text format     Abstract available
    
    
12. KEITEL WA, Voronca DC, Atmar RL, Paust S, et al
    Effect of recent seasonal influenza vaccination on serum antibody responses to candidate pandemic influenza A/H5N1 vaccines: A meta-analysis.
    Vaccine. 2019 May 31. pii: S0264-410X(19)30554.
    PubMed     Text format     Abstract available
    
    
13. NG Y, Nandar K, Chua LAV, Mak TM, et al
    Evaluating the effectiveness of the influenza vaccine during respiratory outbreaks in Singapore's long term care facilities, 2017.
    Vaccine. 2019 May 31. pii: S0264-410X(19)30388.
    PubMed     Text format     Abstract available
    
    
14. RIDDELL CA, Bhat N, Bont LJ, Dupont WD, et al
    Informing randomized clinical trials of respiratory syncytial virus vaccination during pregnancy to prevent recurrent childhood wheezing: A sample size analysis.
    Vaccine. 2018 Nov 22. pii: S0264-410X(18)31407.
    PubMed     Text format     Abstract available
    
    

    
    Virology

15. OHTA K, Matsumoto Y, Nishio M
    Profilin2 is required for filamentous actin formation induced by human parainfluenza virus type 2.
    Virology. 2019;533:108-114.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: